| Автор | Wiexndt, Axel |
| Автор | Amin, Naseem |
| Дата выпуска | 1994 |
| dc.description | The Japanese pharmaceutical industry has lagged behind the US in developing and marhting innovative new compounh. A gap anabsis rebing on international publication and patenting stahtics as well as market survgs shows that the US is the clear leader in biophannaceuticals. Recent Japanese public and private efforts to close the gap have posed no immediate threat to US pharmaceutical companies. The conflict over industrial policy among the ministries involved will take some time to be resolved. However, information networking activities and cross-border technology linkages of Japanese companies should not be underestimated. Biotechnology is current4 transforming theJapanese pharmaceutical induse, and the US will have to deal with a gowing Japanese challenge in the long run. Preventive US counter-measures should include investments in in-house biotechnology research, acquisitions of smaller biotechnology start-up ventures, global commercialization o f biophannaceuticals, and proactive management o f technology linkages with Japanese companies. |
| Формат | application.pdf |
| Издатель | Carfax Publishing Company |
| Копирайт | Copyright Taylor and Francis Group, LLC |
| Название | Biotechnology: the emerging battlefield for US and Japanese pharmaceutical companies |
| Тип | research-article |
| DOI | 10.1080/09537329408524184 |
| Electronic ISSN | 1465-3990 |
| Print ISSN | 0953-7325 |
| Журнал | Technology Analysis & Strategic Management |
| Том | 6 |
| Первая страница | 423 |
| Последняя страница | 436 |
| Аффилиация | Wiexndt, Axel; McKinsey & Co., Inc |
| Аффилиация | Amin, Naseem; Baxter Healthcare International |
| Выпуск | 4 |
| Библиографическая ссылка | Reich, M.R. 1991. Why the Japanese Don't Export More Pharmaceuticals: Health Policy as Industrial Policy. California Management Raview, 33: 124 |
| Библиографическая ссылка | Office of Technology Assessment (OTA), US Congress. 1991. Biotechnology in a Global Economy, 19Washington, DC: US Government Printing Office. |
| Библиографическая ссылка | Pestowitz, C. 1988. Trading Ploces: How We Allowed Japan to Take the Lead, New York: Basic Books. |
| Библиографическая ссылка | Johnson, C. 1982. MITI and theJapanese Mirach, Growth oflndustrial Policy, 1925-1975, 242Stanford, CA: Stanford University Press. |
| Библиографическая ссылка | Audretsch, D.B. 1988. “Eine Evaluation der japanischen F&E- und Industriepolitik”. In Discussion Paper FS IV 88-8, Berlin: Wissenschaftszentnun fär Sozialforschung Berlin. |
| Библиографическая ссылка | von Hippel, E. 1988. The Sources of Innovation, 53Oxford: Oxford University Press. |
| Библиографическая ссылка | Kellogg, J.L. March 1992. Graduate School of Management, March, Northwestern University. As members of an international study group of the we visited Japan and conducted interviews with Exploratory Research for Advanced Technology (ERATO) (Tokyo), the Ministry of International Trade and Industry (MITI) (Tokyo), Kyowa-Hakko Kogyo Co., Ltd. (Tokyo), Eisai Co., Ltd. (Tsukuba), Takeda Chemical Industries, Ltd. (Tokyo), and Nippon Boehringer Ingelheim, Ltd. (Osaka). We would like to express our gratefulness to these institutions and companies for their kind cooperation |
| Библиографическая ссылка | Office of Technology Assessment (OTA), US Congress. op cit 5 Ref 2 |
| Библиографическая ссылка | Daly, P. 1985. The Bwtechnology Buriness, A Strate, Anabsis, London: Pinter. |
| Библиографическая ссылка | Kenney, M. 1986. Biotechnology: The Unversity-Industrial Complex, New Haven: Yale University Press. |
| Библиографическая ссылка | Teitelmann, R. 1991. “Miracles and Mones: The Evolution of a New Industry”. In The Business of Biotechnology, From the Bench to the Street, Edited by: Ono, D.R. 1Boston, MA: Butterworth-Heinemann. |
| Библиографическая ссылка | Yalow, R.S. and Berson, S.A. 1959. Assay of Plasma Insulin in Human Subjects by Immunological Methods. Nature, 184: 1548 |
| Библиографическая ссылка | Kohler, G. and Milstein, C. 1975. Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity. Nature, 200: 495 |
| Библиографическая ссылка | Shamel, R.E. 1991. “Biotechnology Megatrends: Lessons from the Past—Visions of the Future”. In Business of Biotechnology, From the Bench to the Street, Edited by: Ono, D.R. 345Boston, MA: Butterworth-Heinemann. |
| Библиографическая ссылка | Jones, H. 1979. Das Prinzip Verantruortung, Versuch einer Ethik für die technolopische Zivilization, Frankfurt: Insel Verlag. |
| Библиографическая ссылка | National Science Board (NSB). 1991. Science and Engineering Indicators, 388Washington, DC: US Government Printing Office. 10th edn appendix table 5-26 |
| Библиографическая ссылка | 1991. Ibid, : 432 appendix table 6-23 |
| Библиографическая ссылка | Japanese External Trade Organization (JETRO). 1990. “Your Marht in Japan”. In Biotechnology Products, Vol. 46, 22Tokyo: JETRO. |
| Библиографическая ссылка | Burger, T. 1989. Biotechnology in Japan. Biotechnology, 7: 792 |
| Библиографическая ссылка | Reich. 1989. op. cit, 7 Ref 1 |
| Библиографическая ссылка | Japanese External Trade Organization (JETRO). 1990. “Your Marht in Japan, Machinery Market Series M-14”. In Biotechnology Equipment, 6Tokyo: JETRO. Ed |
| Библиографическая ссылка | Akademie der Wissenschaften zu Berlin. 1994. Culture and Technical Innovation, 50Berlin: Walter de Gruyter. Ed |
| Библиографическая ссылка | Arrow, K.J. 1962. “Economic Welfare and the Allocation of Resources for Invention”. In The Rate and Direction of Inventive Activity, 609Princeton, NJ: NBER. National Bureau of Economic Research (NBER) (Ed) |
| Библиографическая ссылка | Chiang, J.T. 1962. From “Mission-oriented” to “Diffusion-oriented” Paradigm: The New Trend of US Industrial Policy. Technovation, 11(191): 339 |
| Библиографическая ссылка | National Science Foundation (NSF). 1989. National Patterns of R&D Resources, Washington, DC: US Government Printing Office. Ed |
| Библиографическая ссылка | Mowery, D.C. 1991. The US National Innovation System: Origins and Prospects for Change. Research Policy, 21: 125 |
| Библиографическая ссылка | Dertouzos, M.L., Lester, R.K. and Solow, R.M., eds. 1989. Made in America, Regaining the Productive Edge, Cambridge, MA: MIT Press. |
| Библиографическая ссылка | Okimoto, D.I. 1989. Between MITI and the Market, Japanese hdurtrial Policy for High Technology, Stanford, CA: Stanford University Press. |
| Библиографическая ссылка | Itho, M., Kiyono, K. and Suzumura, K. 1988. “Industrial Policy as a Corrective to Market Failures”. In Industrial policy of Japan, Edited by: Komiya, R., Okuna, M. and Suzumura, K. 233Tokyo: Academic Press. |
| Библиографическая ссылка | Burril, S.G. and Lee, K.B. 1991. Biotech 91, A Changing Environment, 88San Francisco: Ernst & Young. |
| Библиографическая ссылка | Florida, R.L. and Kenney, M. 1988. Venture Capital-financed Innovation and Technological Change in the USA. Research Policy, 17: 119 |
| Библиографическая ссылка | Anderson, C. 1993. Genome Project Goes Commercial. Science, 259: 300 |
| Библиографическая ссылка | Perry, J. 1986. “Cultivating Technological Innovation”. In Positice Sum stratagies, Edited by: Landau, R. and Rosenberg, N. Washington, DC: National Academy Press. |
| Библиографическая ссылка | Spalding, B.J. 1994. 1993 Public Financing brings in $1.6 billion. Bio/Technology, 12: 119 |
| Библиографическая ссылка | Mansfield, E. 1988. The Speed and Cost of Industrial Innovation in Japan and the US: External vs. Internal Technology. Management Science, 34: 1157 |
| Библиографическая ссылка | Johnson, S.B. 1984. Comparing R&D Strategies of Japanese and US Firms. Sloan Management Review, 25: 25 |
| Библиографическая ссылка | Saxonhouse, G.R. 1986. “Indusmal Policy and Factor Markets: Biotechnology in Japan and the US”. In Japan's High Technology Industry, Edited by: Patrick, H. Washington, DC: University of Washington Press. |
| Библиографическая ссылка | Clymer, S.K. 1991. “Japan's Dilemma: Where and When?”. In The Business of Biotechnology: From the Bench to the Street, Edited by: Ono, R.D. 304Boston, MA: Butterworth-Heinemann. |
| Библиографическая ссылка | Agency of Industrial Science and Technology (AIST). 1991. Points on Major Policies of AIST for Fiscal 1992, Tokyo: AIST. |
| Библиографическая ссылка | 1991. op. cit, : 21 Ref 23 |
| Библиографическая ссылка | Kümmerle, W. 1992. “Global Strategy of Leading Pharmaceutical Enterprises”. In Globablisietung und Wettbewerb, in memoriam Aljed Herhausen, Edited by: Albach, H. Vol. 2/92, 101Wiesbaden: Gabler ZfB Erganzungsheft. |
| Библиографическая ссылка | 1992. op. cit, 2/92: 22 Ref 22 |
| Библиографическая ссылка | National Research Council (NRC), Office of Internation Affairs. 1992. US-Japan technology Linkages in Biotechnology: Challenges for the 1990s, 29Washington, DC: National Academy Press. |
| Библиографическая ссылка | Imai, K. 1988. “Industrial Policy and Technological Innovation”. In Industrial Policy of Japan, Edited by: Komiya, R., Okuno, M. and Suzumura, K. 205Tokyo: Academic Press. |
| Библиографическая ссылка | Ernst and Young, eds. 1991. Biotech 92: PromCce to Reality, An Industry Annual Report, 1San Francisco, CA: Ernst & Young. |
